Trace-Ability Inc.
Los Angeles, CA
- UEI
- S11KA2DGF4J6
- CAGE
- 6YCC3
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 6919 Woodley Ave, Van Nuys, CA 91406, USA
- Website
- traceabilityinc.com
- Founded
- 2013
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase II development of a benchtop laboratory platform | CDC Pittsburgh | $747,804 | |
| Sbir phase i | CDC Pittsburgh | $150,000 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Cellsight Technologies, Inc. | San Francisco, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Petcoil, Inc. | Sunnyvale, CA | — |
| Theracea Pharma LC | Tucson, AZ | — |
| Sofie Biosciences, Inc. | — | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Chesapeake Medical Imaging | — | 621512 Diagnostic Imaging Centers |
About the company
Trace-Ability Inc. is a self-certified small disadvantaged business specializing in the development of advanced technologies for positron emission tomography (PET) imaging. The company focuses on creating automated systems and platforms to improve the production, quality control, and accessibility of PET imaging tracers for various medical applications. Trace-Ability has established partnerships with several federal agencies, including the National Institutes of Health (NIH), Food and Drug Administration (FDA), and National Institute on Aging (NIA), to advance PET imaging technology in areas such as cancer, Alzheimer's disease, and infectious diseases.
In 2019, Trace-Ability was awarded a $747,804 Definitive Firm Fixed Price contract by the Department of Health and Human Services Centers for Disease Control and Prevention. This Small Business Innovation Research (SBIR) Phase II contract supported the development of a benchtop laboratory platform for producing antibody-based PET imaging tracers for HIV. The project aimed to create an automated system that would expand the accessibility of PET imaging technology. Trace-Ability's expertise in PET imaging agents and automated platforms for quality control testing of radiopharmaceuticals was leveraged to fulfill this contract.
Trace-Ability has received several federal grants to further its research and development efforts. In January 2024, the company was awarded a $1,000,000 grant from the National Institute of Allergy and Infectious Diseases (NIAID) to develop an automated system called Tracer-One for the production and quality control of antibody-based HIV PET imaging tracers. Other grant-funded projects include the development of industrial production methods for PET imaging components (National Cancer Institute), a rapid pre-release sterility test for PET drugs (FDA), and the automation of quality control processes for Alzheimer's disease PET tracers (National Institute on Aging). Trace-Ability has also received funding to implement a universal solution for quality control modernization in the PET radiopharmaceutical manufacturing industry through a cooperative agreement with the FDA's Center for Drug Evaluation and Research. These grants demonstrate Trace-Ability's commitment to advancing PET imaging technology across various medical fields and improving its accessibility to a broader patient population.
SBA capabilities narrative
Trace-Ability is a Research and Development Company focused on automation of radio-
pharmaceutical Quality Control via innovative indicators and optical detection
technologies. Trace-Ability's Research and Development activities fall under 2 NAICS
codes:
541715 - Research and Development in the Physical, Engineering and Life Sciences
(Except Nanotechnology and Biotechnology)
541712 - Research and Development in the Physical, Engineering and Life Sciences
(Except Biotechnology)
Quick answers
Is Trace-Ability Inc. registered in SAM.gov?
Yes. Trace-Ability Inc.'s SAM.gov registration is active through November 11, 2026.
What is Trace-Ability Inc.'s most recent federal award?
Trace-Ability Inc.'s most recent federal grant award is Improving availability of immunopet via automation of radio-synthesis and quality control of antibody-based HIV imaging… (R44AI162202), from National Institute of Allergy and Infectious Diseases (NIH), on January 15, 2024.
On GovTribe
See Trace-Ability Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors